Browse by category

Helix has unveiled new clinical research at the American Society of Human Genetics (ASHG) 2024 Annual Meeting, featuring a novel...

Patients on glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - Victoza (Liraglutide 1.8mg), Saxenda (Liraglutide 3mg), Ozempic...

Results from STEP 9 phase 3 clinical trial shows that studied semaglutide 2.4mg, compared to placebo as an adjunct to lifestyle...

Semaglutide has a positive effect on patients with chronic kidney disease and obesity. By decreasing the amount of protein in urine, the...

Semaglutide has demonstrated a significant potential in treating hidradenitis suppurative (HS), a common and chronic skin condition, in...

Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...

Weight reduction at one year is associated with the injectable semaglutide or liraglutide’s active agent, its dosage, treatment...

Semaglutide may help to prevent heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults...

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and weight control...

Taking the weight loss medication semaglutide does not increase the risk of depressive symptoms, suicidal thoughts or suicidal behaviour...